Tracking binding modes of 1,2,4-trisubstituted imidazolinone P38 MAP kinase and ERK-2 inhibitors

被引:2
|
作者
Rao, Shashidhar N. [1 ]
机构
[1] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA
关键词
p38 MAP Kinase; ERK-2; Docking score; DFG-out; Hydrogen bonding; Spearman-R correlation; pi-Cation interactions; ACTIVATED PROTEIN-KINASE; PANCREATIC-CANCER; DOCKING; IDENTIFICATION; DERIVATIVES; PATHWAYS; DESIGN; SMILES; ERK1/2; CELLS;
D O I
10.1016/j.jmgm.2017.07.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Putative binding modes of recently reported p38 MAP Kinase and ERK-2 inhibitors containing 1,2,4-trisubstituted imidazolinone have been investigated using molecular docking methods In the case of p38 MAP Kinase, X-ray structures with both DFG-in and DFG-out conformations of the activation loop have been employed for docking studies. The present investigations demonstrate that the DFG-out conformation of the activation loop in p38 MAP Kinase accommodates the 1,2,4-tri-substituted imidazolinones with greater computed binding affinities than the alternative DFG-in conformation. The best scoring binding modes in ERK-2 are distinctly different from those found in the p38 MAP Kinase structures. Both sets of binding modes are characterized by an extensive network of hydrophobic and pi-cation interactions, with the hinge region showing little hydrogen bonding propensity with the top-ranked poses. Thus, these docking studies provide a putative pathway for lead optimizations in which hydrogen bonding interactions with the hinge region residues are feasible. (c) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:161 / 171
页数:11
相关论文
共 50 条
  • [11] Design, synthesis, and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 MAP kinase inhibitors
    Wrobleski, ST
    Lin, SQ
    Dyckman, A
    Hynes, J
    Li, TL
    Wu, H
    McIntyre, KW
    Schieven, GL
    Zhang, R
    Gillooly, KM
    Pitt, S
    Shen, DR
    Shuster, DJ
    Doweyko, A
    Sack, J
    Barrish, J
    Dodd, J
    Leftheris, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2722 - U2722
  • [12] Pharmacophore Design of p38α MAP Kinase Inhibitors with Either 2,4,5-Trisubstituted or 1,2,4,5-Tetrasubstituted Imidazole Scaffold
    Scior, T.
    Domeyer, D. M.
    Cuanalo-Contreras, K.
    Laufer, S. A.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (10) : 1526 - 1539
  • [13] Two classes of p38α MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes
    Michelotti, EL
    Moffett, KK
    Nguyen, D
    Kelly, MJ
    Shetty, R
    Chai, XM
    Northrop, K
    Namboodiri, V
    Campbell, B
    Flynn, GA
    Fujimoto, T
    Hollinger, FP
    Bukhtiyarova, M
    Springman, EB
    Karpusas, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (23) : 5274 - 5279
  • [14] A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase
    Fox, T
    Coll, JT
    Xie, XL
    Ford, PJ
    Germann, UA
    Porter, MD
    Pazhanisamy, S
    Fleming, MA
    Galullo, V
    Su, MSS
    Wilson, KP
    PROTEIN SCIENCE, 1998, 7 (11) : 2249 - 2255
  • [15] Effects of Water Placement on Predictions of Binding Affinities for p38α MAP Kinase Inhibitors
    Luccarelli, James
    Michel, Julien
    Tirado-Rives, Julian
    Jorgensen, William L.
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2010, 6 (12) : 3850 - 3856
  • [16] Activation of MEF2A by map kinase p38
    Zhao, M
    New, L
    Kato, Y
    Han, J
    FASEB JOURNAL, 1998, 12 (04): : A448 - A448
  • [17] Distinct binding determinants for ERK2/p38α and JNK MAP kinases mediate catalytic activation and substrate selectivity of MAP kinase phosphatase-1
    Slack, DN
    Seternes, OM
    Gabrielsen, M
    Keyse, SM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (19) : 16491 - 16500
  • [18] The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38α MAP kinase
    Down, Kenneth
    Bamborough, Paul
    Alder, Catherine
    Campbell, Amanda
    Christopher, John A.
    Gerelle, Maria
    Ludbrook, Steve
    Mallett, Dave
    Mellor, Geoff
    Miller, David D.
    Pearson, Rosannah
    Ray, Keith
    Solanke, Yemisi
    Somers, Don
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (13) : 3936 - 3940
  • [19] Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase
    Sack, John S.
    Kish, Kevin F.
    Pokross, Matthew
    Xie, Dianlin
    Duke, Gerald J.
    Tredup, Jeffrey A.
    Kiefer, Susan E.
    Newitt, John A.
    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2008, 64 : 705 - 710
  • [20] Predicting the Binding Affinity of P38 Map Kinase Inhibitors using Free Energy Calculations
    Boonyarat, Warabhorn
    Saparpakorn, Patchreenart
    Hannongbua, Supa
    CHIANG MAI JOURNAL OF SCIENCE, 2019, 46 (01): : 93 - 105